推薦產品
product name
发动蛋白抑制剂I ，Dynasore, The Dynamin Inhibitor I, Dynasore, also referenced under CAS 304448-55-3, controls the biological activity of Dynamin. This small molecule/inhibitor is primarily used for Membrane applications.
品質等級
化驗
≥98% (HPLC)
形狀
solid
製造商／商標名
Calbiochem®
儲存條件
OK to freeze
protect from light
顏色
pale yellow
溶解度
DMSO: 16 mg/mL
運輸包裝
ambient
儲存溫度
2-8°C
InChI
1S/C18H14N2O4/c21-15-6-5-11(7-17(15)23)10-19-20-18(24)14-8-12-3-1-2-4-13(12)9-16(14)22/h1-10,21-23H,(H,20,24)/b19-10+
InChI 密鑰
SYNDQCRDGGCQRZ-VXLYETTFSA-N
一般說明
一种细胞可渗透的缩氨基脲化合物，可抑制发动蛋白1/2（IC50 ~15 µM）和Drp1的GTPase活性，对其他两种小GTPases（MxA和Cdc42）没有显著的影响。Dynasore已被用来阐明发动蛋白在网格蛋白包被的和突触小泡介导的内吞作用中的作用。抑制相对于GTP是非竞争性的，并且抑制剂靶位点可能位于GTPase结构域中。显示抑制从质膜上去除wt和ΔF508-CFTR。
包裝
用惰性气体包装
警告
毒性：环境危害（N）
重構
复溶后，等分并冷冻保存（-20°C）。储备溶液在-20°C下可稳定保存至多3个月。
其他說明
Young, A., et al. 2009.Biochem.J., In press.
Nankoe, S.R., and Sever, S. 2006.Trends Cell Biol.16, 607.
Newton, A.J., et al. 2006.Proc.Natl.Acad.Sci. USA103, 17955.
Macia.E., et al. 2006.Dev.Cell10, 839.
Nankoe, S.R., and Sever, S. 2006.Trends Cell Biol.16, 607.
Newton, A.J., et al. 2006.Proc.Natl.Acad.Sci. USA103, 17955.
Macia.E., et al. 2006.Dev.Cell10, 839.
由于该运输中有害物质的性质，您的订单可能需要支付额外的运输费用。某些尺寸的产品可免除其他有害材料的运输费用。请与您当地的销售办事处联系，以获取有关这些费用的更多信息。
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Elsa M Reyes-Reyes et al.
Methods in molecular biology (Clifton, N.J.), 2036, 173-186 (2019-08-15)
Oligonucleotides can be designed or evolved to bind to specific DNA, RNA, protein, or small molecule targets and thereby alter the biological function of the target. The therapeutic potential of oligonucleotides targeted to intracellular molecules will depend largely on their
Alba García-Fernández et al.
Pharmaceutics, 14(7) (2022-07-28)
In this article, we report one of the few examples of nanoparticles capable of simultaneously delivering CRISPR-Cas9 gene-editing machinery and releasing drugs for one-shot treatments. Considering the complexity of inflammation in diseases, the synergistic effect of nanoparticles for gene-editing/drug therapy
Lina Wang et al.
Immunity, 56(2), 272-288 (2023-02-02)
Self-nonself discrimination is vital for the immune system to mount responses against pathogens while maintaining tolerance toward the host and innocuous commensals during homeostasis. Here, we investigated how indiscriminate DNA sensors, such as cyclic GMP-AMP synthase (cGAS), make this self-nonself
Ying Liu et al.
Kidney diseases (Basel, Switzerland), 6(6), 422-433 (2020-12-15)
Levels of urinary microvesicles, which are increased during various kidney injuries, have diagnostic potential for renal diseases. However, the significance of urinary microvesicles as a renal disease indicator is dampened by the difficulty to ascertain their cell source. The aim
Annemiek Dickhout et al.
International journal of molecular sciences, 22(14) (2021-07-25)
The chemokines CCL5 and CXCL4 are deposited by platelets onto endothelial cells, inducing monocyte arrest. Here, the fate of CCL5 and CXCL4 after endothelial deposition was investigated. Human umbilical vein endothelial cells (HUVECs) and EA.hy926 cells were incubated with CCL5
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務